All Stories

  1. Neoadjuvant chemotherapy response influences outcomes in non-colorectal, non-neuroendocrine liver metastases
  2. Suitability of livers for transplantation when treated by normothermic machine perfusion
  3. Parenchymal-sparing hepatectomies (PSH) for bilobar colorectal liver metastases are associated with a lower morbidity and similar oncological results: a propensity score matching analysis
  4. Salvage Versus Primary Liver Transplantation for Early Hepatocellular Carcinoma
  5. Intention-to-treat analysis of percutaneous endovascular treatment of hepatic artery stenosis after orthotopic liver transplantation
  6. Factors influencing recurrence following initial hepatectomy for colorectal liver metastases
  7. Neoadjuvant chemotherapy for intrahepatic cholangiocarcinoma: a new perspective for initially unresectable cases
  8. Superior mesenteric artery “first” approach during pancreaticoduodenectomy: How we do it laparoscopically
  9. Laparoscopic left pancreatectomy: early results after 115 consecutive patients
  10. Repeat liver retransplantation: rationale and outcomes
  11. Serial volumetric assessment of large for size liver grafts after whole cadaveric liver transplant in adults: do large liver grafts shrink in size?
  12. Long-Term Survival Benefit and Potential for Cure after R1 Resection for Colorectal Liver Metastases
  13. Postoperative biological and clinical outcomes following uncomplicated pancreaticoduodenectomy
  14. Spontaneous Splenorenal Shunt in Liver Transplantation
  15. Failure to Achieve a 2-Stage Hepatectomy for Colorectal Liver Metastases
  16. Early and Long-term Oncological Outcomes After Laparoscopic Resection for Colorectal Liver Metastases
  17. Arterial Lactate Concentration at the End of an Elective Hepatectomy Is an Early Predictor of the Postoperative Course and a Potential Surrogate of Intraoperative Events
  18. Dissection technique for selective liver harvesting
  19. Technique de prélèvement hépatique sélectif
  20. Laparoscopic Pancreaticoduodenectomy: Right Posterior Superior Mesenteric Artery “First” Approach
  21. Stump closure reinforcement with absorbable fibrin collagen sealant sponge (TachoSil) does not prevent pancreatic fistula after distal pancreatectomy: the FIABLE multicenter controlled randomized study
  22. Résection hépatique d’au moins 6 segments pour tumeurs malignes : toutes les indications sont-elles légitimes ?
  23. Special Maneuvers in Liver Trauma
  24. Échographie peropératoire du foie
  25. Intra-operative ultrasonography of the liver
  26. Pathologic Major Response After FOLFIRINOX is Prognostic for Patients Secondary Resected for Borderline or Locally Advanced Pancreatic Adenocarcinoma: An AGEO-FRENCH, Prospective, Multicentric Cohort
  27. Parenteral and enteral nutritional support (excluding immunonutrition)
  28. Does pathological response after transarterial chemoembolization for hepatocellular carcinoma in cirrhotic patients with cirrhosis predict outcome after liver resection or transplantation?
  29. Les traitements néo-adjuvants peuvent permettre à des tumeurs non resécables de le devenir
  30. Impact of clinically evident portal hypertension on the course of hepatocellular carcinoma in patients listed for liver transplantation
  31. Pancreatic Adenocarcinoma with Venous Involvement: Is Up-Front Synchronous Portal-Superior Mesenteric Vein Resection Still Justified? A Survey of the Association Française de Chirurgie
  32. Laparoscopic Pancreaticoduodenectomy: Hybrid Surgical Technique
  33. Assistance nutritionnelle parentérale et entérale (hors immunonutrition)
  34. Idiopathic Post Liver-Transplant Hepatitis Remains Obscure with Respect to Its Etiology and Relationship with Immunosuppressiona
  35. Comparison of Complete Pathologic Response and Hepatic Injuries Between Hepatic Arterial Infusion and Systemic Administration of Oxaliplatin in Patients with Colorectal Liver Metastases
  36. Interest of preoperative immunonutrition in liver resection for cancer: study protocol of the PROPILS trial, a multicenter randomized controlled phase IV trial
  37. Two-Stage Hepatectomy Versus 1-Stage Resection Combined With Radiofrequency for Bilobar Colorectal Metastases
  38. Locally Advanced Pancreatic Adenocarcinoma: Reassessment of Response with CT after Neoadjuvant Chemotherapy and Radiation Therapy
  39. Adénocarcinomes du pancréas borderline et localement avancés réséqués après chimiothérapie néo-adjuvante par Folfirinox : résultats d’une étude multicentrique AGEO/FRENCH
  40. Impact de la voie d’administration de l’oxaliplatine : intra-artérielle hépatique ou systémique sur les taux de réponse histologique complète et de lésions au foie non tumoral
  41. Les résultats oncologiques des stratégies en 1 ou 2 temps pour métastases bilobaires de cancer colorectal sont comparables : résultats d’une analyse en intention-de-traiter d’une population appariée
  42. Laparoscopic resection of hepatocellular carcinoma: a French survey in 351 patients
  43. The Postresection Alpha-Fetoprotein in Cirrhotic Patients with Hepatocellular Carcinoma. An Independent Predictor of Outcome
  44. Pancreatic fistula after a pancreaticoduodenectomy for ductal adenocarcinoma and its association with morbidity: a multicentre study of the French Surgical Association
  45. Actual incidence and long-term consequences of posthepatectomy liver failure after hepatectomy for colorectal liver metastases
  46. Posthepatectomy Portal Vein Pressure Predicts Liver Failure and Mortality after Major Liver Resection on Noncirrhotic Liver
  47. Pancreaticoduodenectomy following chemoradiotherapy for locally advanced adenocarcinoma of the pancreatic head
  48. Surgical treatment
  49. Lymph node invasion might have more prognostic impact than R status in advanced esophageal adenocarcinoma
  50. An evaluation of the accuracy of CT when determining resectability of pancreatic head adenocarcinoma after neoadjuvant treatment
  51. Synovialosarcome monophasique primitif du pancréas
  52. 142 DEFINITION OF SARCOPENIA IN CIRRHOTIC PATIENT BEFORE LIVER TRANSPLANTATION
  53. Primary monophasic synovial sarcoma of the pancreas
  54. Laparoscopic Spleen-Preserving Distal Pancreatectomy
  55. Portal stenting for hepatocellular carcinoma extending into the portal vein in cirrhotic patients
  56. New Paradigms in Post-hepatectomy Liver Failure
  57. Une fistule duodénale vraiment difficile à traiter
  58. Wirsungostomy as a salvage procedure after pancreaticoduodenectomy
  59. Réintervention pour échec de fundoplicature. Quels résultats en attendre ?
  60. Re-operation for failed gastro-esophageal fundoplication. What results to expect?
  61. Role of Laparoscopic Distal Pancreatectomy for Solid Pseudopapillary Tumor
  62. Laparoscopic Roux-en-Y gastric bypass: comparison between hand-sewn and mechanical gastrojejunostomy
  63. Splénopancréatectomie gauche pour adénocarcinome du pancréas, par abord antérograde
  64. Left pancreatectomy with splencectomy by the anterograde approach for adenocarcinoma of the pancreas
  65. External Pancreatic Duct Stent Decreases Pancreatic Fistula Rate After Pancreaticoduodenectomy
  66. Cancer colorectal métastatique : repousser les limites de la résécabilité
  67. Modular bioreactor for primary human hepatocyte culture: Medium flow stimulates expression and activity of detoxification genes
  68. Laparoscopic enucleation of pancreatic neoplasm
  69. Annular pancreas
  70. Laparoscopic distal pancreatectomy with splenic preservation
  71. Pancréatectomie gauche avec conservation de la rate sous laparoscopie
  72. Use of Human Hepatocytes to Investigate HCV Infection
  73. Migration intragastrique des anneaux de gastroplastie ajustable
  74. Hepatocellular adenoma management and phenotypic classification: The Bordeaux experience
  75. 740 Hepatocellular Adenomas (HCA) Are Not All the Same: Analysis of 135 Surgically Treated Hca Cases According to the Phenotype Classification; the Bordeaux Experience
  76. P.344 Enucléation laparoscopique de tumeurs du pancréas
  77. P.345 Préservation du parenchyme pancréatique
  78. P.55 Evaluation des résultats à court et long terme des réinterventions pour échec de fundoplicature
  79. A novel pregnane X receptor and S14-mediated lipogenic pathway in human hepatocyte
  80. Hepatocellular adenomas
  81. Internal Radiotherapy of Liver Cancer with Rat Hepatocarcinoma-Intestine-Pancreas Gene as a Liver Tumor-Specific Promoter
  82. Faisabilité et résultats opératoires des résections pancréatiques pour tumeur sous cœlioscopie
  83. Internal radiotherapy of liver cancer with rat Hepatocarcinoma-Intestine-Pancreas gene as a liver tumor-specific promoter
  84. Réintervention pour échec de fundoplicature
  85. A Single-Institution Prospective Study of Laparoscopic Pancreatic Resection
  86. Résultatsd’une seconde chirurgie hépatique pour récidivede métastases de cancer colorectal
  87. A Second Liver Resection Due to Recurrent Colorectal Liver Metastases
  88. Serum-Derived Hepatitis C Virus Infection of Primary Human Hepatocytes Is Tetraspanin CD81 Dependent
  89. Laparoscopic central pancreatectomy: Single institution experience of 6 patients
  90. Isolation, Characterization, and Differentiation to Hepatocyte-Like Cells of Nonparenchymal Epithelial Cells from Adult Human Liver
  91. The low-density lipoprotein receptor plays a role in the infection of primary human hepatocytes by hepatitis C virus
  92. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry
  93. Traitement laparoscopique des hernies hiatales par roulement
  94. RI3 Embolisation portale pre-hepatectomie par amplatzer
  95. Embolisation portale pre-hepatectomie par amplatzer
  96. Laparoscopic versus open approach for solitary insulinoma
  97. Role of CYP3A4 in the regulation of the aryl hydrocarbon receptor by omeprazole sulphide
  98. Subsequent resection of locally advanced pancreatic carcinoma after chemoradiotherapy
  99. Prognostic Factors and Longterm Survival after Hepatic Resection for Hepatocellular Carcinoma Originating from Noncirrhotic Liver
  100. Prise en charge des cancers colorectaux des sujets âgés
  101. Surgical Resection after Radiochemotherapy in Patients with Unresectable Adenocarcinoma of the Pancreas
  102. Pancreaticojejunal Anastomosis Is Preferable to Pancreaticogastrostomy after Pancreaticoduodenectomy for Longterm Outcomes of Pancreatic Exocrine Function
  103. Laparoscopic Adjustable Gastric Banding Results after 2 Years with Two Different Band Types
  104. Prise en charge du cancer colique en occlusion
  105. Clinical, Morphologic, and Molecular Features Defining So-Called Telangiectatic Focal Nodular Hyperplasias of the Liver
  106. Laparoscopic pancreatic resection: A single institution experience with 42 patients
  107. Laparoscopic liver resection for benign and malignant lesions: A feasability and safety study in 35 patients
  108. Pancreaticojejunal anastomosis is preferable to pancreaticogastrostomy after pancreatoduodenectomy in terms of the long-term outcome of pancreatic exocrine function
  109. Obesity as a Risk Factor for Hepatocellular Carcinoma in a Noncirrhotic Patient
  110. Microvascular graft dysfunction
  111. Clinical and molecular analysis of combined hepatocellular-cholangiocarcinomas
  112. Impact of microscopic hepatic lymph node involvement on survival after resection of colorectal liver metastasis1 1No competing interests declared.
  113. The Small Heterodimer Partner Interacts with the Pregnane X Receptor and Represses Its Transcriptional Activity
  114. Les pancréatectomies laparoscopiques
  115. Influence of postoperative morbidity on long-term survival following liver resection for colorectal metastases
  116. Laparoscopic intersphincteric resection with coloplasty and coloanal anastomosis for mid and low rectal cancer
  117. Inhibition of rat hepatocellular carcinoma tumor growth after multiple infusions of recombinant Ad.AFPtk followed by ganciclovir treatment